Sapporo Clinical Laboratory Inc. (JASDAQ:9776) announces a share repurchase program. Under the program, the company will repurchase 20,000 shares, representing 0.57% of the outstanding shares, at ¥1,920 per share for ¥38.4 million. The purpose of the program is to implement a flexible capital policy in response to changes in the business environment. As of February 26, 2018, the company had 3,479,361 shares outstanding and 736,639 shares in treasury.